AU696392B2 - Methods and compositions for treating depression and other disorders using optically pure (+) sibutramine - Google Patents

Methods and compositions for treating depression and other disorders using optically pure (+) sibutramine

Info

Publication number
AU696392B2
AU696392B2 AU48297/97A AU4829797A AU696392B2 AU 696392 B2 AU696392 B2 AU 696392B2 AU 48297/97 A AU48297/97 A AU 48297/97A AU 4829797 A AU4829797 A AU 4829797A AU 696392 B2 AU696392 B2 AU 696392B2
Authority
AU
Australia
Prior art keywords
sibutramine
disorders
compositions
methods
optically pure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU48297/97A
Other versions
AU4829797A (en
Inventor
James W. Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunovion Pharmaceuticals Inc
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/903,094 external-priority patent/US5355153A/en
Priority claimed from AU45429/93A external-priority patent/AU4542993A/en
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of AU4829797A publication Critical patent/AU4829797A/en
Application granted granted Critical
Publication of AU696392B2 publication Critical patent/AU696392B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU48297/97A 1992-06-23 1997-12-11 Methods and compositions for treating depression and other disorders using optically pure (+) sibutramine Ceased AU696392B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/903,094 US5355153A (en) 1991-06-25 1992-06-23 Optical image writing unit having improved driving mechanism
US903034 1992-06-23
AU45429/93A AU4542993A (en) 1992-06-23 1993-06-22 Methods and compositions for treating depression and other disorders using optically pure (+) sibutramine

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU45429/93A Division AU4542993A (en) 1992-06-23 1993-06-22 Methods and compositions for treating depression and other disorders using optically pure (+) sibutramine

Publications (2)

Publication Number Publication Date
AU4829797A AU4829797A (en) 1998-02-19
AU696392B2 true AU696392B2 (en) 1998-09-10

Family

ID=25627179

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48297/97A Ceased AU696392B2 (en) 1992-06-23 1997-12-11 Methods and compositions for treating depression and other disorders using optically pure (+) sibutramine

Country Status (1)

Country Link
AU (1) AU696392B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2837126B2 (en) * 1996-01-23 1998-12-14 三菱重工業株式会社 Single-facer gluing adjustment method and apparatus

Also Published As

Publication number Publication date
AU4829797A (en) 1998-02-19

Similar Documents

Publication Publication Date Title
AU2287495A (en) Methods and compositions for treating depression and other disorders using optically pure s(+) fluoxetine
EP0647134A4 (en) Methods and compositions for treating depression and other disorders using optically pure (-) sibutramine.
EP0708639A4 (en) Methods and compositions for treating depression and other disorders using optically pure (+) sibutramine
AU7323294A (en) Perfluoroelastomeric compositions and methods
AU6904498A (en) Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole
AU3691793A (en) Gas well treatment compositions and methods
AU3201093A (en) Dental composition and method
AU5439996A (en) Compositions and methods for treating pain
EP0748220A4 (en) Methods and compositions for treating androgen-dependent diseases using optically pure r-(-)-casodex
AU7039896A (en) Methods and compositions for treating emesis, nausa and other disorders using optically pure R(+) ondansetron
AU6797094A (en) Cosmetic treatment of substrates
AU2514592A (en) Methods and compositions for modulating g protein action
AU4408593A (en) Methods and activator compositions to disinfect lenses
AU1199888A (en) Communications system and components and methods for use therein
AU3406893A (en) Method and composition for the treatment of osteoporosis
AU6703394A (en) Method of treating depression using neurotrophins
AU6993798A (en) Methods and compositions using optically pure (+)-zileuton
AU3245593A (en) Methods and compositions for treating sleep disorders, convulsive seizures, and other disorders using optically pure (+) zopiclone
EP0700292A4 (en) Methods and compositions for treating gastric disorders using optically pure (+) pantoprazole
AU4468093A (en) Composition and methods for the generation of bone
EP0711159A4 (en) Methods and compositions for treating asthma, atherosclerosis andinflammatory diseases using optically pure (-)-zileuton
AU6599196A (en) Compositions containing analgesics and antihistamines and methods for treating respiratory disorders
AU6660090A (en) Treatment of depression
HU9400129D0 (en) Process for blending of adhesive consisting of two components
AU696392B2 (en) Methods and compositions for treating depression and other disorders using optically pure (+) sibutramine